X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Middle East and South Asia

Symposium tackles adulteration of botanical ingredients

Content Team by Content Team
3rd July 2019
in Middle East and South Asia, Press Statements
Symposium tackles adulteration

Following the great success of last year’s workshop, Euromed is once again partnering with the American Botanical Council (ABC), Extrasynthese, Botanicert and Hylobates to organise a symposium looking at how best to tackle adulteration of botanical ingredients. The event will be hosted within the prestigious 67th International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA) on 1 September 2019 in Innsbruck, Austria.

Entitled Economic Adulteration of Botanical Ingredients, the symposium promises participants a diversified programme, with expert lectures on the different aspects of botanical adulteration and fraud, case studies exploring the health risks associated with counterfeit ingredients, the role of sourcing, as well as prevention tools for the industry and propositions for risk reduction and better quality control.

Adulteration of natural health ingredients is a concern for global industry stakeholders, risk assessors and consumers alike. Despite strict regulations for herbal medicines in the EU, many products that contain botanicals – particularly those sold as food supplements – have reportedly been diluted or substituted with undeclared lower-cost ingredients.

The symposium is a continuation of the initial workshop on adulteration in health ingredients held in November 2018, and will bring together representatives from science, industry and the public sector. Expert speakers include Anna-Rita Bilia from the University of Florence and GA Director; Mark Blumenthal, founder and Executive Director of ABC; Luca Bucchini, Managing Director of Hylobates Consulting; Roy Upton, founder of the American Herbal Pharmacopoeia; René De Vaumas, President of Extrasynthese; Julien Diaz, Botanicert; Anna Mulà, Head of Quality Unit at Euromed; Stefan Gafner, Chief Science Officer of ABC; Débora Frommenwiler, Camag AG, and others that will be confirmed soon.

A round-table discussion will conclude the workshop, with the aim of developing a consensus statement. Important insights will be provided by the US education initiatives from the nonprofit ABC-AHP-NCNPR Botanical Adulterants Prevention Program (BAPP).

As a herbal ingredients supplier, quality management, traceability and supply chain controls are key to Euromed. Andrea Zangara, the company’s Scientific Marketing Manager, explains: “Counterfeit products present a significant challenge to the industry, but more importantly, they put the health of consumers at risk. To support the fight against botanical adulteration and fraud, Euromed and the ABC, with the support of Hylobates Consulting, Extrasynthese and Botanicert, have organised this important symposium to provide insights into the problem and identify tools and practices for prevention.”

Breaks during the programme will provide the opportunity for professional and personal networking. The event will be held at the University of Innsbruck’s Center for Chemistry and Biomedicine. Since the number of places is limited, Euromed recommends registering early.

The pre-congress symposium can be booked alone or in addition to the main congress, which runs until 5 September, via the following link: http://www.ga2019.at/pre-congress-symposia/botanical-ingredient-adulteration.html

About EUROMED:
Founded in 1971 by the German pharmaceutical company MADAUS, EUROMED S.A. is a leading producer of standardised herbal extracts and natural active substances for the pharmaceutical, nutraceutical, food and cosmetics industries.

Annually, a biomass of more than 5,000 tonnes is extracted at the company’s manufacturing facilities in Mollet del Vallès (Barcelona) and Molina de Segura (Murcia), Spain. The production plant in Murcia further expands EUROMED’s capabilities with eco-friendly technologies that use a sophisticated water-based extraction method, the Pure-Hydro Process™.

All extracts comply with worldwide GMP (Good Manufacturing Practice) norms, international pharmacopoeias and regulations. EUROMED has a long history of expertise in research and development, laboratory analyses and extraction technologies and is committed to the highest analytical, chemical and therapeutic quality standards. The company’s skills are now available to the rapidly expanding global nutraceutical market, which is increasingly seeking pharmaceutical-grade, plant-based solutions that support health.

For further information, please visit: www.euromed.es

Previous Post

Herbalife Nutrition Launches Product Line to Meet Consumer Demand for Alternative Proteins

Next Post

Stem Cell Community Day 2019: Bringing the global stem cell research community together on November 21 in Portugal

Related Posts

Cathay Cargo signs global airline partnership with Tower Cold Chain
Packaging & Logistic

Cathay Cargo signs global airline partnership with Tower Cold Chain

31st March 2023
Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging
Europe

Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging

3rd March 2023
Canada's National Carrier Air Canada Cargo and the Cool Tech Company ColdChase join Pharma.Aero
Manufacturing

Canada’s National Carrier Air Canada Cargo and the Cool Tech Company ColdChase join Pharma.Aero

22nd February 2023
Amyris and Immunitybio Complete Joint Venture for Next Generation Covid-19 RNA Vaccine
Drug Development

Clover Launches COVID-19 Booster Vaccine in the People’s Republic of China

21st February 2023
Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea
Clinical Trials

Labcorp Unveils New Name for Future Independent Clinical Development Business – Fortrea

21st February 2023
Agilent Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance
IPR Data Management

Agilent Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance

21st February 2023
Next Post
Stem Cell Community Day 2019: Bringing the global stem cell research community together on November 21 in Portugal

Stem Cell Community Day 2019: Bringing the global stem cell research community together on November 21 in Portugal

Latest News

Cathay Cargo signs global airline partnership with Tower Cold Chain
Packaging & Logistic

Cathay Cargo signs global airline partnership with Tower Cold Chain

31st March 2023
Quotient Sciences completes integration of drug substance into Translational Pharmaceutics Platform
Facilities & Operation

£277m Funding Set To Benefit UK Life Sciences Manufacturing

31st March 2023
Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In